Follow Paris Ziogkas on LinkedIn
Paris's background and expertise lie in project management, e-commerce, and digital health sectors. He has extensive experience in managing multidisciplinary teams and commercializing deep-tech software products. In 2016, he co-founded Advantis Medical Imaging, with a specific focus on developing software tools to assist healthcare professionals in achieving more accurate and timely diagnoses of severe human pathologies such as cancer. His expertise in these areas makes him an effective leader in the development and implementation of innovative healthcare technologies.
As a co-founder of Advantis Medical Imaging, Paris plays a critical role in the company's mission to revolutionize the medical imaging and diagnostics industry. Advantis is disrupting the sector by developing web-based post-processing and 3D visualization MRI software that provides accurate and timely diagnosis of severe human pathologies such as brain and prostate cancer, traumatic brain injury, multiple sclerosis, Alzheimer's, and ALS. Paris's expertise in managing multidisciplinary teams and commercializing deep-tech software products is of great importance in the success of Advantis. His skills are instrumental in driving the development and implementation of the company's pure in-browser and automated imaging software platform. This platform enables the radiology and medical imaging departments of healthcare organizations to diagnose severe human pathologies with greater accuracy and efficiency. The selling points of Advantis's technology are its accuracy, speed, and ease of use. With its innovative software tools, Advantis is making it easier for healthcare professionals to achieve more timely and accurate diagnoses, leading to better patient outcomes. Paris's leadership and expertise in the field are critical to the company's success in disrupting the medical imaging and diagnostics industry, ultimately making a significant impact on improving healthcare for patients around the world
Programs
Year Founded
2016
Year Selected
2021
Stage
Seed
Team Size
21-50
Total Capital Raised
€700,000
Healthcare & Life Sciences
Enterprise Medical Software and Services